Recent DMAC Stock Price | DMAC Stock Predictions | |
$5.36 | +30.60% |
$7.00 |
Recent DMAC Analyst Ratings Breakdown, Making DMAC Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the DMAC stock predictions from the analysts covering DiaMedica Therapeutics Inc, we have collected all of the individual DMAC stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering DMAC (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DMAC stock predictions may vary widely, another useful metric to consider is the median DMAC stock prediction, which represents the price at which half of the analysts
made DMAC stock predictions that were higher and half made DMAC stock predictions that were lower. This makes for a different take on the DMAC stock predictions out there, as compared to average or mean.
And that median across all the individual DMAC stock predictions was: $7.0 as of 2024-12-03.
The very highest of the DMAC stock predictions for one year price target was $8.0, while the very lowest of the DMAC stock predictions in the analyst group was
$6.0 (with a standard deviation of $0.816). Get the latest Zacks research report on DMAC — FREE
Find out: DMAC next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
DKS Stock Predictions
CATY Stock Predictions
FFBC Stock Predictions
RAMP Stock Predictions
ETON Stock Predictions
BAM Stock Predictions
HUBB Stock Predictions
PRGS Stock Predictions
VIR Stock Predictions
|
|
Strong Buy (4.00 out of 4) 94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |